Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 11 10 2017
accepted: 10 12 2018
pubmed: 29 12 2018
medline: 8 10 2019
entrez: 29 12 2018
Statut: ppublish

Résumé

This qualitative study aimed to identify hematopoietic stem cell transplantation (HSCT) survivors' (1) work perceptions; (2) barriers to and facilitators of return to work (RTW); and (3) possible solutions to improve RTW. Fifteen patients treated with HSCT 1-5 years ago participated in face-to-face semi-structured interviews. Interviews were analyzed following the steps of thematic content analyses. RTW was often characterized as a complex and prolonged trajectory, and it was frequently incomplete in working hours, tasks, and/or responsibilities. Work perceptions varied between patients; most valued work as positive, but some also reported a decline in work capacity and/or in importance. Perceived barriers included the duration and side effects of cancer treatment, the presence of comorbidity and poor health before diagnosis, having difficulties commuting and doing household tasks. Perceived facilitators were financial incentives, keeping in touch with the workplace, support of other patients and family, and looking after one's health. Proposed solutions to improve RTW included discussing RTW at the hospital, enhanced employer support, improved accessibility of rehabilitation programs, and more information about the consequences of being sick-listed. Many HSCT survivors value work as important and they are motivated to RTW. Insight in work perceptions, RTW barriers, and solutions might help researchers, healthcare professionals, and employers to develop and/or tailor individualized multidisciplinary care to facilitate RTW.

Identifiants

pubmed: 30591967
doi: 10.1007/s00520-018-4596-0
pii: 10.1007/s00520-018-4596-0
pmc: PMC6597586
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2987-2997

Subventions

Organisme : Dutch Cancer Society/Alpe d'HuZes Fund
ID : ALPE 2009-4620
Organisme : Dutch Cancer Society/Alpe d'HuZes Fund
ID : VU 2011-5045

Références

Eur J Cancer Care (Engl). 2003 Sep;12(3):249-56
pubmed: 12919304
Eur J Cancer. 2005 Nov;41(17):2613-9
pubmed: 16226458
N Engl J Med. 2006 Apr 27;354(17):1813-26
pubmed: 16641398
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Psychooncology. 2009 Feb;18(2):113-27
pubmed: 18677717
Med Sci Sports Exerc. 2009 Apr;41(4):935-46
pubmed: 19276838
Br J Haematol. 2010 Feb;148(3):373-85
pubmed: 19919651
J Cancer Surviv. 2010 Mar;4(1):33-44
pubmed: 19936935
Psychooncology. 2010 Oct;19(10):1078-85
pubmed: 20014202
Blood. 2010 Mar 25;115(12):2508-19
pubmed: 20089962
Eur J Cancer Care (Engl). 2011 Mar;20(2):257-66
pubmed: 20649808
Breast. 2011 Dec;20(6):534-8
pubmed: 21723729
Scand J Work Environ Health. 2012 Mar;38(2):144-54
pubmed: 21986836
Support Care Cancer. 2012 Sep;20(9):1957-64
pubmed: 22033835
Psychooncology. 2013 Jun;22(6):1208-19
pubmed: 22888070
J Clin Oncol. 2012 Oct 20;30(30):3746-51
pubmed: 23008296
Asian Pac J Cancer Prev. 2012;13(11):5791-7
pubmed: 23317258
J Cancer Surviv. 2013 Jun;7(2):237-46
pubmed: 23443319
PLoS One. 2013 May 22;8(5):e63271
pubmed: 23717406
Bone Marrow Transplant. 2014 Jun;49(6):836-42
pubmed: 24614841
J Occup Rehabil. 2015 Mar;25(1):182-96
pubmed: 24832893
J Cancer Surviv. 2014 Dec;8(4):657-70
pubmed: 24993807
J Clin Oncol. 2015 Jun 10;33(17):1918-27
pubmed: 25918291
Support Care Cancer. 2016 Jan;24(1):261-266
pubmed: 26022706
Cochrane Database Syst Rev. 2015 Sep 25;(9):CD007569
pubmed: 26405010
J Psychosoc Oncol. 2016;34(1-2):2-27
pubmed: 26492184
Acta Oncol. 2016 May;55(5):547-53
pubmed: 27123741
Biol Blood Marrow Transplant. 2016 Sep;22(9):1690-1695
pubmed: 27220264
Disabil Rehabil. 2017 Oct;39(21):2164-2172
pubmed: 27596990
Bone Marrow Transplant. 2017 Oct;52(10):1436-1442
pubmed: 28650451
Clin Epidemiol. 2017 Jun 06;9:321-329
pubmed: 28652814
Psychooncology. 2018 Mar;27(3):725-733
pubmed: 28753741

Auteurs

S Persoon (S)

Amsterdam UMC, University of Amsterdam, Rehabilitation Medicine, Amsterdam Movement Sciences institute, Amsterdam, The Netherlands.

L M Buffart (LM)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Biostatistics, Amsterdam Public Health research institute, Amsterdam, The Netherlands.
Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Australia.

M J M Chinapaw (MJM)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam, The Netherlands.

F Nollet (F)

Amsterdam UMC, University of Amsterdam, Rehabilitation Medicine, Amsterdam Movement Sciences institute, Amsterdam, The Netherlands.

M H Frings-Dresen (MH)

Amsterdam UMC, University of Amsterdam, Coronel Institute of Occupational Health, Amsterdam, The Netherlands.

S Koning (S)

Amsterdam UMC, University of Amsterdam, Rehabilitation Medicine, Amsterdam Movement Sciences institute, Amsterdam, The Netherlands.
Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam, The Netherlands.

M J Kersten (MJ)

Amsterdam UMC, University of Amsterdam, Department of Hematology, Amsterdam, The Netherlands.

S J Tamminga (SJ)

Amsterdam UMC, University of Amsterdam, Coronel Institute of Occupational Health, Amsterdam, The Netherlands. s.j.tamminga@amc.uva.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH